Radium-223 for men with hormone-refractory prostate cancer and bone metastases

被引：6
|
作者：
Shelley, Mike D. [1 ]
Mason, Malcolm D.
机构：
[1] Velindre NHS Trust, Cochrane Urol Canc Unit, Cardiff CF14 2TL, Wales
[2] Velindre NHS Trust, Dept Oncol, Cardiff CF14 2TL, Wales
来源：
LANCET ONCOLOGY | 2007年 / 8卷 / 07期
关键词：
D O I：
10.1016/S1470-2045(07)70180-8
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：564 / 565
页数：2
相关论文
共 50 条
  • [31] PROSTATE CANCER Radium-223 safe in combination
    Thoma, Clemens
    NATURE REVIEWS UROLOGY, 2016, 13 (10) : 563 - 563
  • [32] Metabolism and pharmacokinetics of radium-223 in prostate cancer
    Yeku, Oladapo
    Slovin, Susan F.
    EXPERT OPINION ON DRUG METABOLISM & TOXICOLOGY, 2015, 11 (05) : 843 - 849
  • [33] Radionuclide treatment for painful bone metastases in patients with hormone-refractory prostate cancer
    Dolezal, J.
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2007, 34 : S350 - S350
  • [34] Endothelin and skeletal metastases in hormone-refractory prostate cancer
    Hamdy, FC
    EUROPEAN UROLOGY SUPPLEMENTS, 2003, 2 (03) : 15 - 19
  • [35] 223Ra-chloride therapy in men with hormone-refractory prostate cancer and skeletal metastases: Real-world experience
    Boni, Giuseppe
    Mazzarri, Sara
    Cianci, Claudia
    Galli, Luca
    Farnesi, Azzurra
    Borsatti, Eugenio
    Bortolus, Roberto
    Fratino, Lucia
    Gobitti, Carlo
    Lamaj, Elda
    Ghedini, Pietro
    Rizzini, Elisa Lodi
    Massari, Francesco
    Dionisi, Valeria
    Fanti, Stefano
    Volterrani, Duccio
    Monari, Fabio
    TUMORI JOURNAL, 2018, 104 (02): : 128 - 136
  • [36] Use of Radium-223 in Men With Metastatic Castration-Resistant Prostate Cancer
    Parker, Chris
    CLINICAL ADVANCES IN HEMATOLOGY & ONCOLOGY, 2015, 13 (11) : 723 - 725
  • [37] Markers of bone metabolism and survival in men with hormone-refractory metastatic prostate cancer
    Cook, Richard J.
    Coleman, Robert
    Brown, Janet
    Lipton, Allan
    Major, Pierre
    Hei, Yong Jiang
    Saad, Fred
    Smith, Matthew R.
    CLINICAL CANCER RESEARCH, 2006, 12 (11) : 3361 - 3367
  • [38] Utilization of Radium-223 in Metastatic Prostate Cancer Patients and Novel Prognostic Indicators In Radium-223 Patients
    Parsons, M. W.
    Tward, J. D.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2020, 108 (03): : E899 - E899
  • [39] Radium-223 dichloride in castration-resistant prostate cancer with symptomatic bone metastases: a guide to its use
    Shirley M.
    McCormack P.L.
    Drugs & Therapy Perspectives, 2016, 32 (3) : 98 - 103
  • [40] Safety and efficacy of radium-223 dichloride in Japanese patients with castration-resistant prostate cancer and bone metastases
    Hiroji Uemura
    Hirotsugu Uemura
    Nobuaki Matsubara
    Seigo Kinuya
    Makoto Hosono
    Yoko Yajima
    Toshihiko Doi
    International Journal of Clinical Oncology, 2017, 22 : 954 - 963
12345